These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 28230645)
1. Clinical-Scale Rapid Autologous BK Virus-Specific T Cell Line Generation From Kidney Transplant Recipients With Active Viremia for Adoptive Immunotherapy. Lamarche C; Orio J; Georges-Tobar V; Pincez T; Goupil M; Dahmani A; Carli C; Brasey A; Busque L; Delisle JS Transplantation; 2017 Nov; 101(11):2713-2721. PubMed ID: 28230645 [TBL] [Abstract][Full Text] [Related]
2. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients. Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870 [TBL] [Abstract][Full Text] [Related]
3. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation. Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731 [TBL] [Abstract][Full Text] [Related]
4. Antigen-specific T cell responses to BK polyomavirus antigens identify functional anti-viral immunity and may help to guide immunosuppression following renal transplantation. Chakera A; Bennett S; Lawrence S; Morteau O; Mason PD; O'Callaghan CA; Cornall RJ Clin Exp Immunol; 2011 Sep; 165(3):401-9. PubMed ID: 21671906 [TBL] [Abstract][Full Text] [Related]
6. Update on the Management of BK Virus Infection. Saleh A; El Din Khedr MS; Ezzat A; Takou A; Halawa A Exp Clin Transplant; 2020 Nov; 18(6):659-670. PubMed ID: 32552624 [TBL] [Abstract][Full Text] [Related]
7. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation. Ahlenstiel-Grunow T; Pape L Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254 [TBL] [Abstract][Full Text] [Related]
8. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions. Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780 [TBL] [Abstract][Full Text] [Related]
9. Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation. Schaenman JM; Korin Y; Sidwell T; Kandarian F; Harre N; Gjertson D; Lum EL; Reddy U; Huang E; Pham PT; Bunnapradist S; Danovitch GM; Veale J; Gritsch HA; Reed EF Transplantation; 2017 Jun; 101(6):1479-1487. PubMed ID: 27391197 [TBL] [Abstract][Full Text] [Related]
10. BK Polyomavirus Immune Response With Stress on BK-Specific T Cells. El Hennawy HM Exp Clin Transplant; 2018 Aug; 16(4):376-385. PubMed ID: 29766776 [TBL] [Abstract][Full Text] [Related]
11. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients. Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236 [TBL] [Abstract][Full Text] [Related]
12. Cellular immunotherapy for patients with reactivation of JC and BK polyomaviruses after transplantation. Mani J; Jin N; Schmitt M Cytotherapy; 2014 Oct; 16(10):1325-35. PubMed ID: 24934303 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients. Shah T; Vu D; Naraghi R; Campbell A; Min D Clin Transpl; 2014; ():109-16. PubMed ID: 26281134 [TBL] [Abstract][Full Text] [Related]
14. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression. Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant. Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825 [TBL] [Abstract][Full Text] [Related]
16. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients. Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529 [TBL] [Abstract][Full Text] [Related]
17. Different behaviour of BK-virus infection in liver transplant recipients. Umbro I; Tinti F; Muiesan P; Mitterhofer AP World J Gastroenterol; 2016 Jan; 22(4):1532-40. PubMed ID: 26819520 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients. Womer KL; Huang Y; Herren H; Dibadj K; Peng R; Murawski M; Shraybman R; Patton P; Clare-Salzler MJ; Kaplan B Transplantation; 2010 Jan; 89(1):115-23. PubMed ID: 20061927 [TBL] [Abstract][Full Text] [Related]
20. Conversion From Mycophenolates to Mizoribine Is Associated With Lower BK Virus Load in Kidney Transplant Recipients: A Prospective Study. Yuan X; Chen C; Zheng Y; Wang C Transplant Proc; 2018 Dec; 50(10):3356-3360. PubMed ID: 30577207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]